Imported leprosy in Italy

Journal of the European Academy of Dermatology and Venereology

Volumn 26, Issue 8, 2012, Pages 999-1006

  Massone, C ^a,b   Brunasso, A M G ^a,c   Noto, S ^b,d   Campbell, T M ^e   Clapasson, A ^d   Nunzi, E ^b,d  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GENOA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DERMATOLOGIST; DIAGNOSTIC ACCURACY; ENDEMIC DISEASE; FEAR; FEMALE; HEALTH CARE ACCESS; HEALTH CARE SYSTEM; HUMAN; IMMIGRANT; ITALY; LEPROSY; MALE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; VALIDATION PROCESS;

HUMANS; ITALY; LEPROSY; REGISTRIES;

EID: 84864282126     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04201.x     Document Type: Article

References (32)

1. Britton WJ, Lockwood DN,. Leprosy. Lancet 2004; 363: 1209-1219.
2. Faber WR,. Life-threatening mycobacteria infection. Clin Dermatol 2005; 23: 254-257.
3. Smith C, Richardus JH,. Leprosy strategy is about control, not eradication. Lancet 2008; 371: 969-970.
4. Massone C, Nunzi E, Cerroni L,. Histopathologic diagnosis of leprosy in a nonendemic area. Am J Dermatopathol 2010; 32: 417-419.
5. Nunzi E, Massone C, eds. Leprosy: A Pratical Guide in Global Health. Berlin: Springer, 2011; in press.
6. Ridley DS, Jopling WH,. Classification of leprosy according to immunity: a five-group system. Int J Lepr 1966; 34: 255-273.
7. WHO: Enhanced Global Strategy for Further Reducing the Disease Burden Due to Leprosy Operational Guidelines (Updated) (2011-2015). World Health Organization: New Delhi, India. 2009 (SEA-GLP-2009.4).
8. Global leprosy situation, 2004. WHO-Weekly Epidemiological Record 2005; 80: 118-124.
9. Global leprosy situation, 2005. WHO-Weekly Epidemiological Record 2005; 80: 289-296.
10. Global leprosy situation, 2006. WHO-Weekly Epidemiological Record 2006; 81: 309-316.
11. Global leprosy situation, 2007. WHO-Weekly Epidemiological Record 2007, 82: 225-232.
12. Global leprosy situation, beginning of 2008. WHO-Weekly Epidemiological Record 2008; 83: 293-300.
13. Global leprosy situation, 2009. WHO-Weekly Epidemiological Record 2009; 84: 333-340.
14. Global leprosy situation, 2010. WHO-Weekly Epidemiological Record 2010; 85: 337-348.
15. Noto S, Nunzi E,. Global and regional annual 'new case detection' of leprosy reported by World Health Organization. Lepr Rev 2008; 79: 124-127.
16. ISTAT. (accessed 2 April 2011).
17. United Nation Population Division leprosy. (accessed 2 April 2011).
18. OECD. (accessed 2 April 2011).
19. Noto S,. Leprosy statistics 2008. Leprosy Mailing List 2009: October 27th.
20. Bendick C,. Praises and criticisms about the so called leprosy "elimination" policy. Leprosy Mailing List 2009: March 7th.
21. Pannikar V,. Enhanced global strategy 2011-2015. Leprosy Mailing List 2009: August 29th.
22. Post E, Chin-A-Lien RAM, Bouman C, Naafs B, Faber WR,. Leprosy in The Netherlands in the period 1970-1991. Ned Tijdschr Geneesk 1994; 138: 1960-1963.
23. Ganapati R, Pai VV, Rao R,. Dermatologist's role in leprosy elimination/post-elimination. Lepr Rev 2007; 78: 30-33.
24. Porichha D,. The leprosy problem back to the dermatologists. Lepr Rev 2007; 78: 22-25.
25. Nery JA, Schreuder PA, de Mattos PC, et al. Hansen's disease in a general hospital: uncommon presentations and delay in diagnosis. J Eur Acad Dermatol Venereol 2009; 23: 150-156.
26. Naafs B,. Treatment of leprosy: science or politics? Trop Med Int Health 2006; 11: 268-278.
27. Talhari S, Penna G,. Considerations about global policy for leprosy control. Rev Soc Bras Med Trop 2005; 38: 362-364.
28. Ryan T,. Patient and health services delay in the diagnosis of leprosy in Kaduna State, Nigeria. Lepr Rev 2003; 74: 282-283.
29. Massone C, Cavalchini A, Clapasson A, Nunzi E,. Hypopigmented macules: lepromatous leprosy, atopy and Malassezia furfur. G Ital Dermatol Venereol 2010; 145: 779-782.
30. Schieppati A, Henter JI, Daina E, Aperia A,. Why rare diseases are an important medical and social issue. Lancet 2008; 371: 2039-2041.
31. Mira MT, Alcaïs A, Nguyen Ngoca B, Erwin S,. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004; 427: 636-640.
32. Lockwood DN, Reid AJ,. The diagnosis of leprosy is delayed in the United Kingdom. QJM 2001; 94: 207-212.